Geneva, Nov. 3 -- International Clinical Trials Registry received information related to the study (ACTRN12625001161415) titled 'PDE-5 inhibition in Ischaemia with Non-Obstructive Coronary Arteries: a double-blinded, randomised, placebo-controlled trial (PERTINENT)' on Oct. 23.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Primary Sponsor: Sydney Local Health District
Condition:
Ischaemia
Non obstructive coronary artery disease
Ischaemia
Non obstructive coronary artery disease
Cardiovascular - Coronary heart disease
Cardiovascular - Diseases of the vasculature and circulation including the lymphatic system
Intervention:
Participants will be randomised to sildenafil 50mg oral t...